Is this your podcast?
Sign up to track ranks and reviews from iTunes, Stitcher and more
2014 ASCO Annual Meeting
Listen now
Recent Episodes
At ASCO 2014, Dr O'Day provides ecancertv with his expert opinion on the findings from a large phase I study of 411 patients with advanced melanoma which showed that the PD-1 targeting antibody MK-3475 yields long-term responses in a high percentage of patients.
Published 07/15/14
Published 07/15/14
ecancer's Prof McVie provides a roundup of the main points of discussion from ASCO 2014.
Published 07/11/14
Do you host a podcast?
Track your ranks and reviews from iTunes, Stitcher and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »